Company Filing History:
Years Active: 2017
Title: **Ilka Pinz: Innovator in Cardiac Therapeutics**
Introduction
Ilka Pinz, based in Limington, Maine, is a notable inventor whose work focuses on innovative solutions in cardiovascular health. With a dedication to improving patient outcomes, he holds a significant patent that tackles critical issues related to coronary heart disease and related conditions.
Latest Patents
Ilka Pinz's patent titled "Kit for detecting Cthrc1 in a sample" stands out for its potential impact on medical treatments. This invention outlines methods for treating coronary heart disease, peripheral vascular disease, stroke, and ischemia. It utilizes agents that interfere with the expression or activity of Cthrc1, and introduces the use of Cthrc1 peptide as a therapeutic agent for acute or chronic cardiac deficiencies. The patent also emphasizes the detection and monitoring of Cthrc1 peptide in blood or serum, which can be instrumental in assessing cardiac function.
Career Highlights
Ilka Pinz is affiliated with Maine Medical Center, where he applies his expertise to advance research in cardiology. His commitment to innovation has resulted in his significant contributions to the field of cardiac therapeutics, reflecting a strong focus on improving clinical practices and patient care.
Collaborations
Throughout his career, Ilka has worked alongside esteemed colleagues such as Volkhard Lindner and Julia Patrizia Stohn. These collaborations highlight a commitment to interdisciplinary approaches in scientific research, enabling the exploration of novel therapeutic pathways.
Conclusion
Ilka Pinz exemplifies the role of inventors in transforming healthcare through innovative solutions. His patent on the detection of Cthrc1 represents a valuable advancement in the treatment of cardiovascular diseases. As he continues to work with Maine Medical Center and collaborate with fellow professionals, Ilka Pinz remains a significant figure in the field of cardiac innovation.